Arkolith/Insider Trading/ENTO/Form 4

Romano Sarah

Chief Financial OfficerEntero Therapeutics, Inc. (ENTO) · full profile →Form 4 · filed Oct 10, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$214
Net Open-Market Flow
-$214
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 9, 2024Sell(S)476$0.45$21418K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-24-107747) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML